PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
1356929-5	1992	Superoxide anion production, monitored by lucigenin-enhanced chemiluminescence, was inhibited by 40.5% +/- 8.0% (n = 8, P < 0.009) for C5a Des Arg and 47.7% +/- 9.6% (n = 8, P < 0.009) for formyl-methionylleucylphenylalanine stimulation 1.5 h after ingestion of 400 mg of PTOX in a slow-release tablet, with some inhibitory effects persisting at 5 h. There was a strong correlation between reduced PMN response to activated complement and plasma concentrations of three PTOX metabolites (P < 0.05), but not with plasma concentrations of the parent drug.	N-Formylmethionine Leucyl-Phenylalanine	195-230	complement C5a receptor 1	Homo sapiens	138-141	
8106386-1	1994	The N-formylated tripeptide, formylmethionylleucyl-phenylalanine (fMLP), and the 74-amino-acid long human C5a anaphylatoxin activate phagocytic cells via two structurally related G protein-coupled receptors (FPR and C5aR), which are 34% identical in amino acid sequence.	N-Formylmethionine Leucyl-Phenylalanine	29-64	complement C5a receptor 1	Homo sapiens	216-220	
1324680-4	1992	SIN-10 was more effective than SIN-1 in inhibiting superoxide anion (O2-) formation induced by N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMet-Leu-Phe) and by C5a.	N-Formylmethionine Leucyl-Phenylalanine	142-154	complement C5a receptor 1	Homo sapiens	163-166	
1470218-6	1992	In contrast, in the presence of the GTP analogs, GTP[S] and guanosine 5"-[beta,gamma-imino] triphosphate, fMet-Leu-Phe and C5a reduced the binding of [125I]C5a and fMet-Leu-[3H]Phe, respectively, in a concentration-dependent manner.	N-Formylmethionine Leucyl-Phenylalanine	106-118	complement C5a receptor 1	Homo sapiens	156-159	
2190947-4	1990	Chemotaxis towards f-Met-Leu-Phe was inhibited more efficiently by GM-CSF than C5a-induced migration.	N-Formylmethionine Leucyl-Phenylalanine	19-32	complement C5a receptor 1	Homo sapiens	79-82	
6425292-2	1984	The activity of this enzyme in eosinophils isolated from patients with eosinophilia is stimulated (up to 4-fold) in a dose-, time-, and Ca2+/Mg2+-dependent manner after exposure to the eosinophil chemotactic factor of anaphylaxis (ECF-A), C5a, formyl-methionylleucylphenylalanine (fMLP), or ionophore A23187.	N-Formylmethionine Leucyl-Phenylalanine	244-279	complement C5a receptor 1	Homo sapiens	239-242	
3997862-5	1985	The band is eliminated if the cross-linking experiment is performed in the presence of a large excess of unlabeled C5a, but is unaffected by the presence of nonspecific protein or the chemotactic factors N-formyl-Met-Leu-Phe and leukotriene B4.	N-Formylmethionine Leucyl-Phenylalanine	204-224	complement C5a receptor 1	Homo sapiens	115-118